Clinical Trial Update: Neoadjuvant Therapy for Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant therapy trial for epithelial ovarian cancer with involvement of primary peritoneal cancer completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Snippet

Sponsor: Jason D. Wright | Conditions: Epithelial Ovarian Cancer, Primary Peritoneal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-02-09